Arterial stiffness. Disorder of arteries and arterioles, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In treatment group (n=50), curcumin (500 mg/day) is taken orally in subjects over 56 days. Curcumin is purchased from Sami Labs LTD (Bangalore, India). Each 500 mg
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Signed informed consent form Aged above 18 years old Pulse wave velocity above 11.23 m/s
Exclusion criteria
Exclusion criteria: Hepatic failure Biliary obstruction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulse wave velocity. Timepoint: Before and 56 days after the intervention. Method of measurement: SphygmoCor system. | — |
Secondary
| Measure | Time frame |
|---|---|
| PULSE WAVE ANALYSIS. Timepoint: Before and 56 days after the intervention. Method of measurement: SphygmoCor system.;Fasting blood sugar. Timepoint: Before and 56 days after the intervention. Method of measurement: Laboratory kit: Enzymatic method (Glucose Oxidase(.;Lipid profile. Timepoint: Before and 56 days after the intervention. Method of measurement: Laboratory kit: Enzymatic method (Esterases). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Saberi-Karimian
Mashhad University of Medical Sciences
Outcome results
None listed